Pulmonary Artery Enlargement Is Associated With Right Ventricular Dysfunction and Loss of Blood Volume in Small Pulmonary Vessels in Chronic Obstructive Pulmonary Disease

Background—Chronic obstructive pulmonary disease causes significant morbidity and concomitant pulmonary vascular disease and cardiac dysfunction are associated with poor prognosis. Computed tomography–detected relative pulmonary artery (PA) enlargement defined as a PA to ascending aorta diameter ratio >1 (PA:A>1) is a marker for pulmonary hypertension and predicts chronic obstructive pulmonary disease exacerbations. However, little is known about the relationship between the PA:A ratio, pulmonary blood volume, and cardiac function. Methods and Results—A single-center prospective cohort study of patients with chronic obstructive pulmonary disease was conducted. Clinical characteristics and computed tomography metrics, including the PA:A and pulmonary blood vessel volume, were measured. Ventricular functions, volumes, and dimensions were measured by cine cardiac MRI with 3-dimensional analysis. Linear regression examined the relationships between clinical characteristics, computed tomography and cardiac MRI metrics, and 6-minute walk distance. Twenty-four patients were evaluated and those with PA:A>1 had higher right ventricular (RV) end-diastolic and end-systolic volume indices accompanied by lower RV ejection fraction (52±7% versus 60±9%; P=0.04). The PA:A correlated inversely with total intraparenchymal pulmonary blood vessel volume and the volume of distal vessels with a cross-sectional area of <5 mm2. Lower forced expiratory volume, PA:A>1, and hyperinflation correlated with reduced RV ejection fraction. Both PA diameter and reduced RV ejection fraction were independently associated with reduced 6-minute walk distance. Conclusions—The loss of blood volume in distal pulmonary vessels is associated with PA enlargement on computed tomography. Cardiac MRI detects early RV dysfunction and remodeling in nonsevere chronic obstructive pulmonary disease patients with a PA:A>1. Both RV dysfunction and PA enlargement are independently associated with reduced walk distance. Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00608764.

[1]  D. O’Regan,et al.  Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[2]  J. Hisdal,et al.  Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. , 2013, Journal of the American College of Cardiology.

[3]  W. Tracz,et al.  [Evaluation of left ventricular function in patients with chronic obstructive pulmonary disease]. , 2007, Polskie Archiwum Medycyny Wewnetrznej.

[4]  Y. Nişancı,et al.  Early Diagnosis of Right Ventricular Systolic Dysfunction by Tissue Doppler‐Derived Isovolumic Myocardial Acceleration in Patients with Chronic Obstructive Pulmonary Disease , 2009, Echocardiography.

[5]  Carl-Fredrik Westin,et al.  Lung Extraction, Lobe Segmentation and Hierarchical Region Assessment for Quantitative Analysis on High Resolution Computed Tomography Images , 2009, MICCAI.

[6]  E. Hoffman,et al.  Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies. , 2013, Chest.

[7]  B. Lipworth,et al.  Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial. , 2014, The Lancet. Respiratory medicine.

[8]  J. Wells,et al.  CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. , 2014, Chest.

[9]  Kuncheng Li,et al.  Evaluation of right ventricular function by 64-row CT in patients with chronic obstructive pulmonary disease and cor pulmonale. , 2012, European journal of radiology.

[10]  Eric A. Hoffman,et al.  Percent emphysema, airflow obstruction, and impaired left ventricular filling. , 2010, The New England journal of medicine.

[11]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[12]  A. Peacock,et al.  Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension , 2009, European Respiratory Journal.

[13]  W. Qin,et al.  Assessment of the right ventricular function in patients with chronic obstructive pulmonary disease using MRI , 2011, Acta radiologica.

[14]  J. Marcus,et al.  The effect of right ventricular hypertrophy on left ventricular ejection fraction in pulmonary emphysema. , 1997, Chest.

[15]  Raúl San José Estépar,et al.  Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. , 2013, American journal of respiratory and critical care medicine.

[16]  S. Petersen,et al.  Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity , 2010, Heart.

[17]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[18]  Mario J. Garcia,et al.  Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. , 2009, JACC. Cardiovascular imaging.

[19]  M. Bogdan,et al.  Prevalence and Characteristics of Pulmonary Hypertension Associated with COPD - A Pilot Study in Patients Referred to a Pulmonary Rehabilitation Program Clinic. , 2013, Maedica.

[20]  F. Maltais,et al.  Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. , 2005, Chest.

[21]  Meilan K. Han,et al.  Pulmonary arterial enlargement and acute exacerbations of COPD. , 2012, The New England journal of medicine.

[22]  A. Malhotra,et al.  Evaluation of Right Ventricular Remodeling Using Cardiac Magnetic Resonance Imaging in Co-Existent Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea , 2013, COPD.

[23]  Carl-Fredrik Westin,et al.  Automatic Lung Lobe Segmentation Using Particles, Thin Plate Splines, and Maximum a Posteriori Estimation , 2010, MICCAI.

[24]  T. Durmaz,et al.  Treatment of acute chronic obstructive pulmonary disease exacerbation improves right ventricle function. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[25]  V L Morgan,et al.  Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[26]  J. Wild,et al.  Comparison of the Diagnostic Utility of Cardiac Magnetic Resonance Imaging, Computed Tomography, and Echocardiography in Assessment of Suspected Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease , 2012, The Journal of Rheumatology.

[27]  R. Souza,et al.  Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension? , 2012, The American journal of cardiology.

[28]  J. Marcus,et al.  Early changes of cardiac structure and function in COPD patients with mild hypoxemia. , 2005, Chest.

[29]  Johan H. C. Reiber,et al.  A strain energy filter for 3D vessel enhancement with application to pulmonary CT images , 2011, Medical Image Anal..

[30]  J. Machan,et al.  Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease , 2011, Lung.

[31]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[32]  B. Celli,et al.  Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[33]  Ritesh Agrawal,et al.  Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease , 2011, Lung India : official organ of Indian Chest Society.

[34]  J. Barberà,et al.  Echocardiographic abnormalities in patients with COPD at their first hospital admission , 2012, European Respiratory Journal.

[35]  Thomas Schultz,et al.  Computational vascular morphometry for the assessment of pulmonary vascular disease based on scale-space particles , 2012, 2012 9th IEEE International Symposium on Biomedical Imaging (ISBI).

[36]  T. Petty,et al.  Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. , 2000, Chest.

[37]  R. Upton,et al.  Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. , 2007, Chest.

[38]  Carl-Fredrik Westin,et al.  Sampling and Visualizing Creases with Scale-Space Particles , 2009, IEEE Transactions on Visualization and Computer Graphics.

[39]  Carl-Fredrik Westin,et al.  Automatic airway analysis for genome-wide association studies in COPD , 2012, 2012 9th IEEE International Symposium on Biomedical Imaging (ISBI).

[40]  H. Gupta,et al.  Right Ventricular Function Assessment: Comparison of Geometric and Visual Method to Short‐Axis Slice Summation Method , 2007, Echocardiography.

[41]  J. Barberà,et al.  Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial , 2013, European Respiratory Journal.

[42]  M. Tamm,et al.  Acute Effects of Aerosolized Iloprost in COPD Related Pulmonary Hypertension - A Randomized Controlled Crossover Trial , 2012, PloS one.

[43]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[44]  G. Criner,et al.  Stability of improvements in exercise performance and quality of life following bilateral lung volume reduction surgery in severe COPD. , 1997, Chest.